semaglutide drug names Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity GLP-1 Weight Loss Medication -

This study is expected to be completed in November 2024.

Qsymia has become a second-line option, recommended when GLP-1 medications are not tolerated, not accessible, or contraindicated

Removal of chronic blood clots from the lungs can lead to complete resolution of the pulmonary hypertension. For group 1s pulmonary arterial hypertension, there are now 17 drugs developed over the last 25 years that can ease symptoms and prolong life

Expensive drugs, not necessarily covered by insurers

The study also reported improvements in cardiometabolic risk factors such as waist circumference, blood pressure, cholesterol levels, blood sugar markers, and inflammation